LUNG - Pulmonx Corporation
About Pulmonx Corporation (https://pulmonx.com)
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Geoffrey Beran Rose | Chief Commercial Officer | 1974 | $632,293 USD |
| David A. Lehman | General Counsel & Secretary | 1961 | $516,643 USD |
| Glendon E. French | Chief Executive Officer, President & Director | 1962 | $319,520 USD |
| Derrick Sung | Chief Financial Officer & Chief Operating Officer | 1973 | $283,391 USD |
| John McKune | VP of Finance & Corporate Controller | 1976 | – |
| Jérôme Erath | Senior Vice President & GM of International | – | – |
| Lisa Paul | Chief People Officer | 1964 | – |
| Marcee Maroney | Vice President of Marketing | 1970 | – |
| Narinder S. Shargill | Senior Vice President of Global Medical & Clinical Affairs | 1955 | – |
| Sri Radhakrishnan | Chief Science & Technology Officer | – | – |
| Srikanth Radhakrishnan | Chief Science & Technology Officer | 1973 | – |